Herzliya Medical Center is a private hospital in Herzliya, Israel that offers therapeutic care, laboratory services, physiotherapy, air-ambulance, and medical tourism services. The hospital was founded in 1983. Herzelia medical center is the biggest private hospital in Israel, with over 5000 employees.

There are 80 beds in Herzliya Medical Center.

During the past decade, Herzliya Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herzliya Medical Center" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "CarboFix Orthopedics Ltd." with 1 trials sponsored, "ParaSonic Ltd." with 1 trials sponsored, "STS Medical" with 1 trials sponsored and "Theranica" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herzliya Medical Center" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Herzliya Medical Center" are "Acute Migraine" (1 trials), "Chronic Sinusitis" (1 trials), "Degenerative Disc Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Pediculus Capitis" (1 trials). Many other conditions were trialed in "Herzliya Medical Center" in a lesser frequency.

Most popular intervention types in "Herzliya Medical Center" are "Device" (4 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Composite Removable Sinus Stent" (1 trials), "Linagliptin" (1 trials), "Nerivio Migra neurostimulation" (1 trials), "Pedicle screw system" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzliya Medical Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Herzliya Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Herzliya Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Herzliya Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".